This paper is in the following e-collection/theme issue:

COVID-19 Vaccination (155) JMIR Theme Issue: COVID-19 Special Issue (2461) Infectious Diseases (non-STD/STI) (1592) Outbreak and Pandemic Preparedness and Management (1743) Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (1520) Vaccination and Immunization in the Digital Age (378) Hygiene and Infection Prevention (325)

Published on in Vol 8, No 11 (2022): November

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/38898, first published .
The Risk of Hospitalization and Mortality After Breakthrough SARS-CoV-2 Infection by Vaccine Type: Observational Study of Medical Claims Data

The Risk of Hospitalization and Mortality After Breakthrough SARS-CoV-2 Infection by Vaccine Type: Observational Study of Medical Claims Data

The Risk of Hospitalization and Mortality After Breakthrough SARS-CoV-2 Infection by Vaccine Type: Observational Study of Medical Claims Data

Authors of this article:

Meghana Kshirsagar1 Author Orcid Image ;   Md Nasir1 Author Orcid Image ;   Sumit Mukherjee2 Author Orcid Image ;   Nicholas Becker1, 3 Author Orcid Image ;   Rahul Dodhia1 Author Orcid Image ;   William B Weeks1 Author Orcid Image ;   Juan Lavista Ferres1 Author Orcid Image ;   Barbra Richardson4 Author Orcid Image
Article Authors Cited by (5) Tweetations (6) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.